Facebook Linkedin Twitter
Inside Precision Medicine Finer Cancer Screens Catch More Cancer Clues

Diagnostic techniques

Some researchers believe that while tumor genome profiling identifies driver mutations in breast tumors
Molecular Dx

Finer Cancer Screens Catch More Cancer Clues

Patricia Fitzpatrick Dimond, Ph.D.
0
DiaSorin to Acquire Quest’s Focus Diagnostics for $300M
News & Features

DiaSorin to Acquire Quest’s Focus Diagnostics for $300M

0
Newly developed technology enhances the sensitivity of liquid bipopsy methods [NIH]
Molecular Dx

Liquid Biopsy Sensitivity Dramatically Enhanced

0
The FDA insists it is not looking to derail ctDNA or stop development of new technologies. [Rutchapong/iStock]
News & Features

Getting Testy Over Liquid Biopsies

0
Blood test shows new mutations in NRAS and PI3K genes may lead to skin cancer relapse. [iStock/ftwitty]
Molecular Dx

Liquid Biopsy May Provide Early Warning of Skin Cancer Relapse

0
This image shows a stained kidney sample imaged on a two-photon microscope with blue representing nuclei and red cytoplasm. [Cody Narciso and Victoria Zellmer/University of Notre Dame]
News & Features

New 3D Biopsy Design Greatly Improves Diagnostic Potential

0
Exosomal RNA-Based Liquid Biopsy
News & Features

Exosomal RNA-Based Liquid Biopsy

0
The primers used for library preparation during the development of the BRCA1 and BRCA2 panels were scored by QC
Molecular Dx

Designing Amplicon Panels

Radmila Hrdlickova , April Lewis and Jiri Nehyba
0
PCR is a fast and inexpensive technique used to amplify segments of DNA. Because significant amounts of a sample of DNA are typically necessary for molecular and genetic analyses
Molecular Dx

PCR Has a History of Amplifying Its Game

Jeffrey S. Buguliskis, Ph.D.
0
Clinical OMICs Magazine: Volume 3
News & Features

Clinical OMICs Magazine Volume 3, Issue No. 3

0
1...165166167...182Page 166 of 182

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine